why choose us

Course: Bamlanivimab for Prevention of COVID-19

CME Credits: 1.00

Released: 2021-06-03

Passive immunotherapy has played an essential role in the prevention and treatment of infectious diseases since Emil von Behring’s Nobel Prize–winning work in the 1890s on the use of antiserum raised in horses to treat diphtheria. This work paved the way for use of antiserum to treat tetanus and prevent rabies, and for Rufus Cole’s development of type-specific immune serum to treat pneumococcal pneumonia, published in 1913. By the mid-20th century, advances in clinical immunology led to the use of immune globulins, comprising primarily immunoglobulin G, harvested from persons with high-titer antibodies to provide postexposure prophylaxis against varicella-zoster virus (varicella-zoster immune globulin), hepatitis B virus (hepatitis B immune globulin), and other viral infections. Convalescent plasma, obtained from individuals who have recovered from a particular viral infection, has been used to varying effect in the treatment of influenza during the 1918 pandemic and for Ebola, severe acute respiratory syndrome, and COVID-19.,


Educational Objective
To identify the key insights or developments described in this article


View Full Course